AI inventing biological viruses: the next frontier of risk beyond cybercrime

Recent disclosures suggest that AI inventing biological viruses is no longer speculative fiction but an emerging reality that could eclipse traditional cybercrime.

AI inventing biological viruses – a strategic blind spot

Scientists at leading labs report algorithms capable of stitching together viral genomes in silico, a step that accelerates the design cycle from years to days. The Reuters investigation notes a ↑ 45% rise in research funding for synthetic pathogen projects since 2022.

“If we cannot police code, we cannot police contagion,” warns biosecurity analyst Dr. Lina Ortega.

Governments are scrambling to adapt existing AP News frameworks, yet the legal toolbox remains rooted in pandemic era statutes that lack provisions for AI‑driven bio‑threats.

Policy gaps and market response

Venture capital flows toward defensive biotech have dipped, with a ↓ 12% contraction in the last quarter, while threat‑intel firms report a surge in demand for AI‑augmented surveillance tools.